OSTEOGENESIS IMPERFECTA (OI)
Clinical trials for OSTEOGENESIS IMPERFECTA (OI) explained in plain language.
Never miss a new study
Get alerted when new OSTEOGENESIS IMPERFECTA (OI) trials appear
Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA (OI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study tests a new medicine called AGA2115 in adults with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. The goal is to see if it safely increases bone density compared to a placebo. About 80 adults aged 18 to 75 will participate, and the main measure is …
Matched conditions: OSTEOGENESIS IMPERFECTA (OI)
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
Brittle bone disease linked to heart risks – new study aims to uncover clues
Knowledge-focused Recruiting nowThis study looks at heart structure and function in people with osteogenesis imperfecta (OI), a condition that makes bones fragile. Researchers want to learn how often heart problems occur in people with OI and how they change over time. The goal is to help doctors screen for hea…
Matched conditions: OSTEOGENESIS IMPERFECTA (OI)
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated May 17, 2026 06:47 UTC